News | January 20, 2022
Green chemistry approaches to synthesis could make a big difference to pharma product outputs
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation
New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha, Gamma and Omicron variants following third dose booster with Vaxzevria
Under the terms of the agreement, Arrakis will lead research activities for the identification of RNA-targeted small molecule (rSM) binders against a broad set of targets nominated by Amgen
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma
The latest research results indicated that JMB2002 had high binding activity to the Omicron variant and showed potent Omicron pseudovirus neutralization function
With two maintenance doses a year, Leqvio is the first and only FDA-approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol) reduction1
Neutralising antibody levels against Omicron following a third dose boost of Vaxzevria were broadly similar to levels achieved after two doses against the Delta variant
The Uteshiya facility, licensed by Healthium, will exclusively manufacture Healthium’s arthroscopy portfolio, including patented products in India and U.S.
Healtherbs helps in restoring the desired energy levels for daily activity and immunity
Subscribe To Our Newsletter & Stay Updated
